Cite

HARVARD Citation

    Huang, R. et al. (2015). Myeloablative haploidentical hematopoietic stem cell transplantation using basiliximab for graft-versus-host disease prophylaxis. Hematology. 20 (6), pp. 313-319. [Online]. 
  
Back to record